Radiotherapy and OncologyVolume 163, Supplement 1, October 2021, Page S4397: Four-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated with Ablative Therapies: The Sprat AnalysisAuthor links open overlay panelRachel Glicksman, Amar U. Kishan, Alan J. Katz, Constantine A. Mantz, Sean P. Collins, Donald B. Fuller, Michael L. Steinberg, David Shabsovich, Liying Zhang, Andrew LoblawShow moreShareCitehttps://doi.org/10.1016/S0167-8140(21)08975-1Get rights and contentRecommended articlesReferences (0)Cited by (0)View full textCopyright © 2021 Elsevier Ireland Ltd. All rights reserved.
